Home/HBOX Therapies/Dr. Ing. Peter Schlanstein
DI

Dr. Ing. Peter Schlanstein

Co-Founder, Managing Director, CTO

HBOX Therapies

HBOX Therapies Pipeline

DrugIndicationPhase
MiRA SystemAcute Respiratory Failure (ARF)Pre-clinical